54
edits
Important: The GCConnex decommission will not affect GCCollab or GCWiki. Thank you and happy collaborating!
Changes
Jump to navigation
Jump to search
PHAC Conflict of Interest Toolkit for Guideline Development (view source)
Revision as of 18:09, 7 October 2020
, 18:09, 7 October 2020Added updated links for Canadian Task Force on Preventive Healthcare COI resources (disclosure form and algorithm)
Line 78:
Line 78:
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-clinician_coi-declaration.docx CADTH pan-Canadian Oncology Drug Review disclosure of interest form for clinicians]
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-clinician_coi-declaration.docx CADTH pan-Canadian Oncology Drug Review disclosure of interest form for clinicians]
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-patientad-coi-declaratio.doc CADTH pan-Canadian Oncology Drug Review disclosure of interest form for patient groups]
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-patientad-coi-declaratio.doc CADTH pan-Canadian Oncology Drug Review disclosure of interest form for patient groups]
−* [https://canadiantaskforce.ca/wp-content/uploads/2016/12/procedural-manual-en_2014_Archived.pdf Canadian Task Force on Preventive Healthcare disclosure of interest form] (see Appendix 1)
+* [https://canadiantaskforce.ca/wp-content/uploads/2020/10/COI-Policy-202008Final-1.pdf Canadian Task Force on Preventive Healthcare disclosure of interest form] (see Appendix 1)
* [https://community.cochrane.org/sites/default/files/uploads/EPPR/Cochrane-COI-disclosure-form.pdf Cochrane Collaboration disclosure of interest form]
* [https://community.cochrane.org/sites/default/files/uploads/EPPR/Cochrane-COI-disclosure-form.pdf Cochrane Collaboration disclosure of interest form]
* [https://www.uspto.gov/sites/default/files/documents/OGE450_June_2015.pdf US FDA financial disclosure report – Executive Branch]
* [https://www.uspto.gov/sites/default/files/documents/OGE450_June_2015.pdf US FDA financial disclosure report – Executive Branch]
Line 105:
Line 105:
=== Examples of algorithms/process maps for COI management ===
=== Examples of algorithms/process maps for COI management ===
+* [https://canadiantaskforce.ca/wp-content/uploads/2020/10/COI-Policy-202008Final-1.pdf Canadian Task Force on Preventive Healthcare algorithm for disclosure of interests and management of COI] (see Appendix 3)
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i14 American Thoracic Society COI resolution procedure]
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i14 American Thoracic Society COI resolution procedure]
* [https://cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-coi-guidelines.pdf CADTH pan-Canadian Oncology Drug Review COI management overview] (Appendix A)
* [https://cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-coi-guidelines.pdf CADTH pan-Canadian Oncology Drug Review COI management overview] (Appendix A)
